Matches in Nanopublications for { ?s ?p "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP262605.RAZpIMOxg_C5yH81ZOAlWZqUMbMxFeQI0Zu9bGY6hYLRo130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262605.RAZpIMOxg_C5yH81ZOAlWZqUMbMxFeQI0Zu9bGY6hYLRo130_provenance.
- NP263736.RAesYHdWtSp-fA4Fr_vqIpUBieOQlF21FY2y4Fh8EJ7aA130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263736.RAesYHdWtSp-fA4Fr_vqIpUBieOQlF21FY2y4Fh8EJ7aA130_provenance.
- NP298575.RAcTwcqk5hhzmS8qS7oNuAtlNDh5lLIrmPnblzca6VWJU130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298575.RAcTwcqk5hhzmS8qS7oNuAtlNDh5lLIrmPnblzca6VWJU130_provenance.
- assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP914473.RA7EBc79FXOx6FNs8jgOYqA_zD4d9l1soqHNeis1SR5_c130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914473.RA7EBc79FXOx6FNs8jgOYqA_zD4d9l1soqHNeis1SR5_c130_provenance.
- NP914482.RA8hxm-OQ2i3LSA3vnQ0xE3N5Rf7wFQzV4UOlcHg2Zyv8130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914482.RA8hxm-OQ2i3LSA3vnQ0xE3N5Rf7wFQzV4UOlcHg2Zyv8130_provenance.
- NP914476.RARf3g848VNuLBuZcHrdT4d3JLnIxkR3QtHGsPiCrV0nE130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914476.RARf3g848VNuLBuZcHrdT4d3JLnIxkR3QtHGsPiCrV0nE130_provenance.
- NP298497.RAtlj36E5F5wNdeaBcLGD9ynwU67Vg9Jb52qFD2wm8RS0130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298497.RAtlj36E5F5wNdeaBcLGD9ynwU67Vg9Jb52qFD2wm8RS0130_provenance.
- NP914474.RAhntoU0C25qgc1yoTJZkip2ISmVHiqAf0pUQNdA6zJjU130_assertion description "[Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914474.RAhntoU0C25qgc1yoTJZkip2ISmVHiqAf0pUQNdA6zJjU130_provenance.